- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06389565
Pilot Randomized Clinical Trial of Change My Story
April 24, 2024 updated by: Aimalohi Ahonkhai, Massachusetts General Hospital
Change My Story: Pilot Randomized Clinical Trial of Change My Story Among Young Persons Living With HIV and Depression
Psychological distress and depression are common among young people living with HIV (Y-PLWH) and negatively impact medication adherence and disease control.
In low- and middle-income countries, this problem is compounded by the lack of trained mental health professionals on the provider side and the requirement of frequent clinic-based visits imposing greater cost, inconvenience, and stigma for patients.
Change My Story, is a theory-grounded, interactive narrative game designed to address the key drivers of depression and psychological distress among Y-PLWH in Nigeria.
This pilot hybrid implementation-effectiveness randomized controlled trial (RCT) will compare Change My Story combined with PST to PST alone among 80 Y-PLWH with depression or psychological distress.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Young people living with HIV (Y-PLWH) have poor adherence to antiretroviral therapy and engagement in HIV care, making HIV the leading cause of death for African adolescents.
Depression and psychological distress are much more common among Y-PLWH than in the general population, and are associated with significantly worse adherence to care and treatment when compared to Y-PLWH without these co-morbid conditions.
Thus, untreated depression and severe psychological distress are important contributors to poor HIV outcomes in this population.
Nigeria is home to the 4th largest HIV population globally and 10% of Y-PLWH, but mental health screening is not routinely conducted in this setting, and less than 10% of those diagnosed have access to evidence-based care.
Despite this treatment gap, few interventions have targeted the mental health needs of Y-PLWH in Africa.
The World Health Organization recommends that caregivers of Y-PLWH adopt youth-friendly strategies and incorporate psychosocial services to meet their needs, and that task shifting to non-specialized health workers be used to overcome the dearth of trained professionals in low and middle-income countries.
Task-shifted problem Solving Therapy (PST) has been effectively used to treat both depression and psychological distress using a task-shifted approach.
However, PST is an intensive strategy (typically 6-15 weekly sessions) often delivered in-person and poor completion rates are associated with less effectiveness -- a concern further magnified during the current COVID-19 climate.
Mobile health technologies may be uniquely suited to surmount some of the obstacles for effective A theory-grounded game, Change My Story, has been developed which allows players navigate difficult experiences based on drivers of psychological distress and interact with a virtual environment this research aims to 1) conduct a hybrid implementation-effectiveness pilot RCT for 80 Y-PLWH with depression or psychological distress, and compare feasibility, acceptability, engagement, satisfaction and preliminary effectiveness among individuals receiving PST alone or PST with Change My Story, and 2) use the Consolidated Framework for Implementation Research (CFIR) to assess factors influencing engagement, acceptability, and satisfaction along with facilitators and barriers to implementation delivery.
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Aima a Ahonkhai, MD
- Phone Number: 617-726-3906
- Email: AAHONKHAI@mgh.harvard.edu
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- HIV-positive
- age 16-24 years
- self-reported proficiency in reading and understanding English.
- PHQ9 score of 8-17 and impairment in functioning (consistent with clinical depression)
Exclusion Criteria:
- pregnant or nursing
- in care and on ART for <6 months
- history of- or positive assessment for- bipolar or psychotic disorder.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: PST alone
Patients randomized to PST alone will receive PST delivered using a stepped-care approach.
Subsequent care will be determined based on participant PHQ-9 score at the week 6 evaluation.
All participants who do not achieve remission (PHQ-9 <12) after completion of the additional six-week therapy sessions, will be required to have a referral to either the general MD or psychiatrist at the clinic to determine need for pharmacologic treatment or additional intervention based on local clinical practice guidelines.
During each PST session, the HIV counselor will ask the participant structured questions to identify those at risk of suicide, or with adverse reactions to prescribed antidepressants.
Participants who indicate suicidality (plan/attempt) during PST sessions, or ongoing refractory disease (at reassessment points) will require immediate consultation by the psychiatry clinic.
|
Problem solving therapy (PST) is a cognitive-behavioral therapy (CBT)-based intervention that uses seven basic steps to teach problem solving orientation and skills to equip individuals to manage the impact of stressful life events on their mental health.
|
Experimental: PST with Change My Story
In addition to all activities described in the PST alone arm, at enrollment, participants in the arm with Change My Story, will download the game onto their phones, receive instructions about the game and receive recommendations on how to play the game (at least one narrative for one of the three characters) each week within 48 hours of the PST session.
Participants will be encouraged to set a weekly reminder alarm for their game play session.
Participants will have an opportunity to explore the game at will according to these loose parameters prior to the first PST session.
|
Problem solving therapy (PST) is a cognitive-behavioral therapy (CBT)-based intervention that uses seven basic steps to teach problem solving orientation and skills to equip individuals to manage the impact of stressful life events on their mental health.
Change My Story is a narrative game with a choose-your-own-adventure format in which players navigate emotionally difficult experiences along with the character(s) and interact with the virtual environment to choose a narrative path toward the story's conclusion.
It will used to address important obstacles in the mental health treatment gap for Y-PLWH.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Engagement
Time Frame: 3 months
|
The percentage of recommended problem solving therapy sessions attended.
|
3 months
|
Satisfaction
Time Frame: 3 months
|
Based on an adapted version of the client satisfaction questionnaire (CSQ-8).
Total scores range from 8 to 32, with the higher number indicating greater satisfaction.
|
3 months
|
Feasibility 1
Time Frame: 3 months
|
Weiner's feasibility of an intervention (FIM).
Scales can be created for each measure by averaging responses.
Scale values range from 1 to 5.
|
3 months
|
Feasibility 2
Time Frame: 3 months
|
Proportion of consented patients enrolled
|
3 months
|
Feasibility 3
Time Frame: 3 months
|
Proportion of game play sessions interrupted by technical problems
|
3 months
|
Feasibility 4
Time Frame: 3 months
|
Proportion of users requiring mobile phone (at baseline) or requiring a replacement phone (due to loss or theft)
|
3 months
|
Feasibility 5
Time Frame: Baseline
|
Proportion of users requiring mobile phone
|
Baseline
|
Feasibility 6
Time Frame: 3 months
|
Proportion of users requiring mobile phone replacement due to loss or theft
|
3 months
|
Feasibility 7
Time Frame: 3 months
|
Proportion in need for additional data bundles
|
3 months
|
Acceptability 1
Time Frame: Once
|
Weiner's acceptability of an intervention.
Scales can be created for each measure by averaging responses.
Scale values range from 1 to 5.
|
Once
|
Acceptability 2
Time Frame: up to 3 months
|
Number of minutes of total game play per month
|
up to 3 months
|
Acceptability 3
Time Frame: up to 3 months
|
Number of days of total game play per month
|
up to 3 months
|
Acceptability 4
Time Frame: 3 months
|
Percentage of recommended game play minutes completed
|
3 months
|
Acceptability 5
Time Frame: 3 months
|
Proportion of narratives completed assessed from aggregated game play metrics
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Remission of depression.
Time Frame: 3 and 6 months
|
Patient health questionnaire-9.
For this research, a PHQ-9 score < 6 will be considered in remission.
|
3 and 6 months
|
Remission of psychological distress.
Time Frame: 3 and 6 months
|
Self reporting questionnaire-20.
For this research, a SRQ-20 < 5 will be considered in remission.
|
3 and 6 months
|
ART adherence
Time Frame: 3 and 6 months
|
Based on % pharmacy refill
|
3 and 6 months
|
Viral suppression
Time Frame: 3 and 6 months
|
VL < 200 copies/mL
|
3 and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 1, 2025
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
June 30, 2026
Study Registration Dates
First Submitted
April 9, 2024
First Submitted That Met QC Criteria
April 24, 2024
First Posted (Actual)
April 29, 2024
Study Record Updates
Last Update Posted (Actual)
April 29, 2024
Last Update Submitted That Met QC Criteria
April 24, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024p000857
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
Clinical Trials on Problem Solving Therapy
-
University of WashingtonNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
University of OttawaOttawa Hospital Research InstituteActive, not recruiting
-
Washington University School of MedicineNurses for Newborns FoundationCompletedPost-partum DepressionUnited States
-
VA Office of Research and DevelopmentCompletedDepression | AnxietyUnited States
-
University of PittsburghNational Institute of Mental Health (NIMH)CompletedMild Cognitive ImpairmentUnited States
-
University of California, San FranciscoSan Francisco Veterans Affairs Medical CenterCompletedMajor Depressive DisorderUnited States
-
Lawson Health Research InstituteUniversity of Western Ontario, Canada; Queen's UniversityWithdrawn
-
Instituto Nacional de Psiquiatría Dr. Ramón de...Universidad Nacional Autonoma de MexicoTerminatedDiabetes Mellitus, Type 2Mexico
-
University of California, San DiegoSan Diego State UniversityCompleted
-
University of PittsburghNational Institute of Mental Health (NIMH)Completed